This inventor holds 2 USPTO granted patents. Top assignees: Urigen Pharmaceuticals, Inc., Vaneltix Pharma, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Christopher Meenan: Innovator in Local Anesthetic Formulations
Introduction
Christopher Meenan is an accomplished inventor based in North Brunswick, NJ (US). He holds 2 patents that focus on innovative formulations for local anesthetics. His work has significantly contributed to advancements in medical treatments, particularly for urinary tract conditions.
Latest Patents
One of Christopher Meenan's latest patents is an article of manufacture comprising a local anesthetic, buffer, and glycosaminoglycan in a syringe with improved stability. This invention includes a composition that combines a glycosaminoglycan, a local anesthetic, and a buffer, all packaged in a syringe or vial made from either glass or specific plastics. The selected materials include cyclic olefin polymer, cyclic olefin copolymer, or high-density non-nucleated polypropylene. This composition has shown unexpectedly improved stability during storage and can be formulated for treating urinary tract diseases, such as interstitial cystitis, also known as bladder pain syndrome or hypersensitive bladder syndrome.
Career Highlights
Throughout his career, Christopher has worked with notable companies in the pharmaceutical industry. He has been associated with Vaneltix Pharma, Inc. and Urigen Pharmaceuticals, Inc., where he has contributed to the development of innovative medical solutions.
Collaborations
Christopher has collaborated with talented professionals in his field, including Dan Vickery and Andreas Meier. Their combined expertise has fostered advancements in the development of effective medical treatments.
Conclusion
Christopher Meenan is a notable inventor whose work in local anesthetic formulations has made a significant impact in the medical field. His innovative patents and collaborations highlight his commitment to improving patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile